We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $21.5B
1-Year Est. Return 81.81%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+81.81%
3 Year Est. Return
+226.72%
5 Year Est. Return
+294.21%
10 Year Est. Return
AUM
$9.03B
AUM Growth
-$1.37B
Cap. Flow
-$1.22B
Cap. Flow %
-13.56%
Top 10 Hldgs %
18.31%
Holding
2,015
New
576
Increased
314
Reduced
307
Closed
636

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$18.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$17.4M
3
INSM icon
Insmed
INSM
+$16.1M
4
GILD icon
Gilead Sciences
GILD
+$15.8M
5
K
Kellanova
K
+$15.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 88.58%
2 Healthcare 3.09%
3 Consumer Discretionary 2.5%
4 Technology 1.62%
5 Financials 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
776
CALL
Amgen
AMGN
$206B
$1.68M 0.02%
+6,000
New +$1.7M
LRCX icon
777
Lam Research
LRCX
$335B
$1.67M 0.02%
17,200
+8,200
+91% +$650K
AKRO
778
DELISTED
Akero Therapeutics
AKRO
$1.67M 0.02%
31,338
+26,738
+581% +$1.21M
RRR icon
779
PUT
Red Rock Resorts
RRR
$3.17B
$1.67M 0.02%
32,100
PVH icon
780
PVH
PVH
$3.42B
$1.66M 0.02%
+24,239
New +$1.76M
ASO icon
781
PUT
Academy Sports + Outdoors
ASO
$3.06B
$1.66M 0.02%
+37,100
New +$1.54M
MAG
782
DELISTED
MAG Silver
MAG
$1.65M 0.02%
78,000
XOP icon
783
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.05B
$1.64M 0.02%
+13,050
New +$1.56M
PRAX icon
784
Praxis Precision Medicines
PRAX
$8.56B
$1.64M 0.02%
39,036
+20,756
+114% +$790K
DNTH icon
785
CALL
Dianthus Therapeutics
DNTH
$5.66B
$1.64M 0.02%
88,100
+63,400
+257% +$1.19M
NWPX icon
786
PUT
NWPX Infrastructure Inc
NWPX
$990M
$1.64M 0.02%
+40,000
New +$1.61M
FNV icon
787
CALL
Franco-Nevada
FNV
$51.3B
$1.64M 0.02%
10,000
MQ icon
788
Marqeta
MQ
$1.67B
$1.63M 0.02%
+70,000
New +$1.33M
JD icon
789
CALL
JD.com
JD
$36.3B
$1.63M 0.02%
50,000
-293,600
-85% -$10M
DK icon
790
CALL
Delek US
DK
$5B
$1.63M 0.02%
77,000
-37,000
-32% -$622K
DAL icon
791
Delta Air Lines
DAL
$52.2B
$1.62M 0.02%
+33,000
New +$1.52M
MKSI icon
792
MKS Inc
MKSI
$16.3B
$1.62M 0.02%
16,328
+4,128
+34% +$335K
ARM icon
793
PUT
Arm
ARM
$283B
$1.62M 0.02%
10,000
LDOS icon
794
Leidos
LDOS
$16.5B
$1.6M 0.02%
10,129
-34,771
-77% -$5.14M
MRUS
795
CALL
DELISTED
Merus
MRUS
$1.58M 0.02%
30,000
-240,000
-89% -$11.3M
LW icon
796
Lamb Weston
LW
$6.39B
$1.58M 0.02%
+30,397
New +$1.63M
KOS icon
797
PUT
Kosmos Energy
KOS
$1.7B
$1.57M 0.02%
915,300
HMY icon
798
CALL
Harmony Gold Mining
HMY
$12.5B
$1.57M 0.02%
+112,500
New +$1.7M
CYD icon
799
China Yuchai International
CYD
$1.3B
$1.56M 0.02%
65,300
+25,436
+64% +$446K
ZETA icon
800
CALL
Zeta Global
ZETA
$7.65B
$1.55M 0.02%
+100,000
New +$1.33M

Similar funds

Caption Management's Q2 2025 Portfolio in Review

As of Q2 2025, Caption Management held 2,015 positions worth $9.03B, down 13% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management withdrew a net $1.22B in Q2 2025, closing 636 positions and reducing 307 holdings. Its most notable exit was Microsoft, an estimated $394M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, up from 79% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Caption Management opened a new position in Skechers worth $20.1M.

  • Caption Management's largest Q2 2025 buy was Skechers: 317,932 shares worth $20.1M.
  • Caption Management added most to Kellanova in Q2 2025, an estimated $15.3M increase.
  • Caption Management's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $121M.
  • Caption Management fully exited Microsoft in Q2 2025, selling an estimated $394M.
  • Caption Management's ten largest holdings make up 18% of its $9.03B portfolio in Q2 2025.
  • Caption Management opened 576 new positions and closed 636 in Q2 2025.
  • Caption Management's portfolio value fell 13% quarter-over-quarter to $9.03B.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.